TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J

Journal of Experimental Medicine

Volumn 209, Issue 2, 2012, Pages 319-334

  Zhao, Baohong ^a   Grimes, Shannon N ^a   Li, Susan ^a   Hu, Xiaoyu ^a,b   Ivashkiv, Lionel B ^a,b,c  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; JAGGED1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFATC1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; GENE DELETION; GENETIC VECTORS; IMMUNOBLOTTING; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; INTERFERON REGULATORY FACTORS; MICE; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; REAL-TIME POLYMERASE CHAIN REACTION; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863116031     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20111566     Document Type: Article

References (58)

1. Androutsellis-Theotokis, A., R.R. Leker, F. Soldner, D.J. Hoeppner, R. Ravin, S.W. Poser, M.A. Rueger, S.K. Bae, R. Kittappa, and R.D. McKay. 2006. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature. 442:823-826. http://dx.doi.org/10.1038/nature04940
2. Azuma, Y., K. Kaji, R. Katogi, S. Takeshita, and A. Kudo. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275:4858-4864. http://dx.doi.org/10.1074/jbc.275.7.4858
3. Bai, S., R. Kopan, W. Zou, M.J. Hilton, C.T. Ong, F. Long, F.P. Ross, and S.L. Teitelbaum. 2008. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem. 283:6509-6518. http://dx.doi.org/10.1074/jbc.M707000200
4. Beres, T.M., T. Masui, G.H. Swift, L. Shi, R.M. Henke, and R.J. MacDonald. 2006. PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L. Mol. Cell. Biol. 26:117- 130. http://dx.doi.org/10.1128/MCB.26.1.117-130.2006
5. Boyce, B.F., E.M. Schwarz, and L. Xing. 2006. Osteoclast precursors: cytokinestimulated immunomodulators of inflammatory bone disease. Curr. Opin. Rheumatol. 18:427-432. http://dx.doi.org/10.1097/01.bor.0000231913.32364.32
6. Caton, M.L., M.R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204:1653-1664.
7. Engin, F., and B. Lee. 2010. NOTCHing the bone: insights into multifunctionality. Bone. 46:274-280. http://dx.doi.org/10.1016/j.bone.2009.05.027
8. Engin, F., Z. Yao, T. Yang, G. Zhou, T. Bertin, M.M. Jiang, Y. Chen, L. Wang, H. Zheng, R.E. Sutton, et al. 2008. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 14:299-305. http://dx.doi.org/10.1038/nm1712
9. Foldi, J., A.Y. Chung, H. Xu, J. Zhu, H.H. Outtz, J. Kitajewski, Y. Li, X. Hu, and L.B. Ivashkiv. 2010. Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. J. Immunol. 185:5023-5031. http://dx.doi.org/10.4049/jimmunol.1001544
10. Fukushima, H., A. Nakao, F. Okamoto, M. Shin, H. Kajiya, S. Sakano, A. Bigas, E. Jimi, and K. Okabe. 2008. The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis. Mol. Cell. Biol. 28:6402-6412. http://dx.doi.org/10.1128/MCB.00299-08
11. Hayward, S.D. 2004. Viral interactions with the Notch pathway. Semin. Cancer Biol. 14:387-396. http://dx.doi.org/10.1016/j.semcancer.2004.04.018
12. Hilton, M.J., X. Tu, X. Wu, S. Bai, H. Zhao, T. Kobayashi, H.M. Kronenberg, S.L. Teitelbaum, F.P. Ross, R. Kopan, and F. Long. 2008. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14:306-314. http://dx.doi.org/10.1038/nm1716
13. Hu, X., C. Herrero, W.P. Li, T.T. Antoniv, E. Falck-Pedersen, A.E. Koch, J.M. Woods, G.K. Haines, and L.B. Ivashkiv. 2002. Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat. Immunol. 3:859-866. http://dx.doi.org/10.1038/ni828
14. Hu, R., S.M. Sharma, A. Bronisz, R. Srinivasan, U. Sankar, and M.C. Ostrowski. 2007. Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors. Mol. Cell. Biol. 27:4018-4027. http://dx.doi.org/10.1128/MCB.01839-06
15. Hu, X., A.Y. Chung, I. Wu, J. Foldi, J. Chen, J.D. Ji, T. Tateya, Y.J. Kang, J. Han, M. Gessler, et al. 2008. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity. 29:691-703. http://dx.doi.org/10.1016/j.immuni.2008.08.016
16. Isidor, B., P. Lindenbaum, O. Pichon, S. Bézieau, C. Dina, S. Jacquemont, D. Martin-Coignard, C. Thauvin-Robinet, M. Le Merrer, J.L. Mandel, et al. 2011. Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat. Genet. 43:306-308. http://dx.doi.org/10.1038/ng.778
17. Ivashkiv, L.B., and X. Hu. 2003. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum. 48:2092-2096. http://dx.doi.org/10.1002/art.11095
18. Izumiya, Y., C. Izumiya, D. Hsia, T.J. Ellison, P.A. Luciw, and H.J. Kung. 2009. NF-kappaB serves as a cellular sensor of Kaposi's sarcomaassociated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J. Virol. 83:4435-4446. http://dx.doi.org/10.1128/JVI.01999-08
19. Kim, N., Y. Kadono, M. Takami, J. Lee, S.H. Lee, F. Okada, J.H. Kim, T. Kobayashi, P.R. Odgren, H. Nakano, et al. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202:589-595. http://dx.doi.org/10.1084/jem.20050978
20. Kim, K., J.H. Kim, J. Lee, H.M. Jin, H. Kook, K.K. Kim, S.Y. Lee, and N. Kim. 2007. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood. 109:3253-3259. http://dx.doi.org/10.1182/blood-2006-09-048249
21. Kitaura, H., P. Zhou, H.J. Kim, D.V. Novack, F.P. Ross, and S.L. Teitelbaum. 2005. M-CSF mediates TNF-induced inflammatory osteolysis. J. Clin. Invest. 115:3418-3427. http://dx.doi.org/10.1172/JCI26132
22. Kobayashi, K., N. Takahashi, E. Jimi, N. Udagawa, M. Takami, S. Kotake, N. Nakagawa, M. Kinosaki, K. Yamaguchi, N. Shima, et al. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKLRANK interaction. J. Exp. Med. 191:275-286. http://dx.doi.org/10.1084/jem.191.2.275
23. Kopan, R., and M.X. Ilagan. 2009. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 137:216-233. http://dx.doi.org/10.1016/j.cell.2009.03.045
24. Lam, J., S. Takeshita, J.E. Barker, O. Kanagawa, F.P. Ross, and S.L. Teitelbaum. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106:1481-1488. http://dx.doi.org/10.1172/JCI11176
25. Lee, J., K. Kim, J.H. Kim, H.M. Jin, H.K. Choi, S.H. Lee, H. Kook, K.K. Kim, Y. Yokota, S.Y. Lee, et al. 2006. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood. 107:2686-2693. http://dx.doi.org/10.1182/blood-2005-07-2798
26. Li, J., I. Sarosi, X.Q. Yan, S. Morony, C. Capparelli, H.L. Tan, S. McCabe, R. Elliott, S. Scully, G. Van, et al. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA. 97:1566-1571. http://dx.doi.org/10.1073/pnas.97.4.1566
27. Li, P., E.M. Schwarz, R.J. O'Keefe, L. Ma, B.F. Boyce, and L. Xing. 2004. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J. Bone Miner. Res. 19:207-213. http://dx.doi.org/10.1359/JBMR.0301233
28. Locksley, R.M., N. Killeen, and M.J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104:487- 501. http://dx.doi.org/10.1016/S0092-8674(01)00237-9
29. Maillard, I., T. Fang, and W.S. Pear. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23:945-974. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115747
30. Miyauchi, Y., K. Ninomiya, H. Miyamoto, A. Sakamoto, R. Iwasaki, H. Hoshi, K. Miyamoto, W. Hao, S. Yoshida, H. Morioka, et al. 2010. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J. Exp. Med. 207:751-762. http://dx.doi.org/10.1084/jem.20091957
31. Murtaugh, L.C., B.Z. Stanger, K.M. Kwan, and D.A. Melton. 2003. Notch signaling controls multiple steps of pancreatic differentiation. Proc. Natl. Acad. Sci. USA. 100:14920-14925. http://dx.doi.org/10.1073/pnas.2436557100
32. Nishikawa, K., T. Nakashima, M. Hayashi, T. Fukunaga, S. Kato, T. Kodama, S. Takahashi, K. Calame, and H. Takayanagi. 2010. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl. Acad. Sci. USA. 107:3117-3122. http://dx.doi.org/10.1073/pnas.0912779107
33. Novack, D.V., and S.L. Teitelbaum. 2008. The osteoclast: friend or foe? Annu. Rev. Pathol. 3:457-484. http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151431
34. Oka, C., T. Nakano, A. Wakeham, J.L. de la Pompa, C. Mori, T. Sakai, S. Okazaki, M. Kawaichi, K. Shiota, T.W. Mak, and T. Honjo. 1995. Disruption of the mouse RBP-J kappa gene results in early embryonic death. Development. 121:3291-3301.
35. Plaisance, S., W. Vanden Berghe, E. Boone, W. Fiers, and G. Haegeman. 1997. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell. Biol. 17:3733-3743.
36. Raychaudhuri, S., B.P. Thomson, E.F. Remmers, S. Eyre, A. Hinks, C. Guiducci, J.J. Catanese, G. Xie, E.A. Stahl, R. Chen, et al; BIRAC Consortium; YEAR Consortium. 2009. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 41:1313-1318. http://dx.doi.org/10.1038/ng.479
37. Rogatsky, I., K.A. Zarember, and K.R. Yamamoto. 2001. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20:6071-6083. http://dx.doi.org/10.1093/emboj/20.21.6071
38. Schett, G., and S.L. Teitelbaum. 2009. Osteoclasts and arthritis. J. Bone Miner. Res. 24:1142-1146. http://dx.doi.org/10.1359/jbmr.090533
39. Sethi, G., B. Sung, A.B. Kunnumakkara, and B.B. Aggarwal. 2009. Targeting TNF for Treatment of Cancer and Autoimmunity. Adv. Exp. Med. Biol. 647:37-51. http://dx.doi.org/10.1007/978-0-387-89520-8_3
40. Sethi, N., X. Dai, C.G. Winter, and Y. Kang. 2011. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell. 19:192-205. http://dx.doi.org/10.1016/j.ccr.2010.12.022
41. Shimizu, T., T. Kagawa, T. Inoue, A. Nonaka, S. Takada, H. Aburatani, and T. Taga. 2008. Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol. Cell. Biol. 28:7427-7441. http://dx.doi.org/10.1128/MCB.01962-07
42. Simpson, M.A., M.D. Irving, E. Asilmaz, M.J. Gray, D. Dafou, F.V. Elmslie, S. Mansour, S.E. Holder, C.E. Brain, B.K. Burton, et al. 2011. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat. Genet. 43:303-305. http://dx.doi.org/10.1038/ng.779
43. Stahl, E.A., S. Raychaudhuri, E.F. Remmers, G. Xie, S. Eyre, B.P. Thomson, Y. Li, F.A. Kurreeman, A. Zhernakova, A. Hinks, et al; BIRAC Consortium; YEAR Consortium. 2010. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42:508-514. http://dx.doi.org/10.1038/ng.582
44. Takayanagi, H. 2007. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7:292-304. http://dx.doi.org/10.1038/nri2062
45. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:443-450. http://dx.doi.org/10.1038/ni793
46. Taniguchi, Y., T. Furukawa, T. Tun, H. Han, and T. Honjo. 1998. LIM protein KyoT2 negatively regulates transcription by association with the RBP-J DNA-binding protein. Mol. Cell. Biol. 18:644-654.
47. Tao, J., S. Chen, T. Yang, B. Dawson, E. Munivez, T. Bertin, and B. Lee. 2010. Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent. J. Bone Miner. Res. 25:2175-2183. http://dx.doi.org/10.1002/jbmr.115
48. Taylor, P.C., and M. Feldmann. 2009. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol. 5:578- 582. http://dx.doi.org/10.1038/nrrheum.2009.181
49. Teitelbaum, S.L. 2006. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8:201. http://dx.doi.org/10.1186/ar1857
50. Terato, K., K.A. Hasty, R.A. Reife, M.A. Cremer, A.H. Kang, and J.M. Stuart. 1992. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148:2103-2108.
51. Vaira, S., T. Johnson, A.C. Hirbe, M. Alhawagri, I. Anwisye, B. Sammut, J. O'Neal, W. Zou, K.N. Weilbaecher, R. Faccio, and D.V. Novack. 2008. RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci. USA. 105:3897-3902. http://dx.doi.org/10.1073/pnas.0708576105
52. Yamada, T., H. Yamazaki, T. Yamane, M. Yoshino, H. Okuyama, M. Tsuneto, T. Kurino, S. Hayashi, and S. Sakano. 2003. Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood. 101:2227-2234. http://dx.doi.org/10.1182/blood-2002-06-1740
53. Yao, Z., P. Li, Q. Zhang, E.M. Schwarz, P. Keng, A. Arbini, B.F. Boyce, and L. Xing. 2006. Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J. Biol. Chem. 281:11846-11855. http://dx.doi.org/10.1074/jbc.M512624200
54. Yao, Z., L. Xing, and B.F. Boyce. 2009. NF-kappaB p100 limits TNFinduced bone resorption in mice by a TRAF3-dependent mechanism. J. Clin. Invest. 119:3024-3034. http://dx.doi.org/10.1172/JCI38716
55. Yarilina, A., E. DiCarlo, and L.B. Ivashkiv. 2007. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J. Immunol. 178:2204-2211.
56. Zanotti, S., A. Smerdel-Ramoya, L. Stadmeyer, D. Durant, F. Radtke, and E. Canalis. 2008. Notch inhibits osteoblast differentiation and causes osteopenia. Endocrinology. 149:3890-3899. http://dx.doi.org/10.1210/en.2008-0140
57. Zhao, B., and L.B. Ivashkiv. 2011. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res. Ther. 13:234-243. http://dx.doi.org/10.1186/ar3379
58. Zhao, B., M. Takami, A. Yamada, X. Wang, T. Koga, X. Hu, T. Tamura, K. Ozato, Y. Choi, L.B. Ivashkiv, et al. 2009. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat. Med. 15:1066-1071. http://dx.doi.org/10.1038/nm.2007